Iguratimod
Iguratimod is a pharmaceutical drug with 20 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
6
Mid Stage
9
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
3
trials recruiting
20
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITP
Efficacy Study of Iguratimod Combined With Tofacitab in Patients With RF Positive/Negative Rheumatoid Arthritis
Safety and Efficacy of Iguratimod in the Treatment of Chronic GVHD
The Clinical Efficacy and Safety of Iguratimod in RA and Early RA Patients for 6 Months Treatment
The Efficacy and Safety of Tofacitinib (TF) With Iguratimod (IGU) on RA
Clinical Trials (20)
Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITP
Efficacy Study of Iguratimod Combined With Tofacitab in Patients With RF Positive/Negative Rheumatoid Arthritis
Safety and Efficacy of Iguratimod in the Treatment of Chronic GVHD
The Clinical Efficacy and Safety of Iguratimod in RA and Early RA Patients for 6 Months Treatment
The Efficacy and Safety of Tofacitinib (TF) With Iguratimod (IGU) on RA
The Clinical Efficacy of Immunomodulators in RA Patients
The Combination of Iguratimod and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
Efficacy and Safety of Iguratimod in the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
Efficacy and Safety of Iguratimod in Patients With Hand Osteoarthritis (ESIGO)
A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome.
A Study of Iguratimod in Patients With Active Rheumatoid Arthritis
Iguratimod in Systemic Sclerosis
The Iguratimod Effect on Lupus Nephritis (IGeLU)
Investigation of the Safety and Efficacy of Iguratimod in Patients With Rheumatoid Arthritis
Iguratimod in Kidney Transplant Recipients
Iguratimod as Treatment for Refractory Lupus Nephritis
Study of Iguratimod in Sjögren's Syndrome
Long-term Efficacy of Iguratimod Alone or Iguratimod in Combination With Methotrexate in Patients With Rheumatoid Arthritis
Study of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in Patients With Rheumatoid Arthritis
Effectiveness of Iguratimod Versus Placebo to Treat Early Rheumatoid Arthritis on MRI
All 20 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 20